81 related articles for article (PubMed ID: 20875366)
21. [Benign increase of tumor marker Ca 12-5 in pelvic peritonitis with ascites].
Löseke A; Salfelder A; Blees M; Hickl EJ
Geburtshilfe Frauenheilkd; 1996 Jul; 56(7):365-7. PubMed ID: 8964451
[TBL] [Abstract][Full Text] [Related]
22. Carbohydrate antigen-125: additional accuracy in identifying patients at risk of acute heart failure in acute coronary syndrome.
De Gennaro L; Brunetti ND; Bungaro R; Montrone D; Cuculo A; Pellegrino PL; Correale M; Di Biase M
Coron Artery Dis; 2009 Jun; 20(4):274-80. PubMed ID: 19440066
[TBL] [Abstract][Full Text] [Related]
23. Pelvic-peritoneal tuberculosis simulating ovarian carcinoma: report of three cases with elevation of the CA 125.
Nistal de Paz F; Herrero Fernández B; Pérez Simón R; Fernández Pérez E; Nistal de Paz C; Ortoll Battle P; Muñoz Rodríguez M
Am J Gastroenterol; 1996 Aug; 91(8):1660-1. PubMed ID: 8759688
[TBL] [Abstract][Full Text] [Related]
24. The effect of simple laparoscopic surgery on the serum level of the tumour marker CA 125.
Willett MJ; Watson AJ
Eur J Obstet Gynecol Reprod Biol; 2004 May; 114(1):75-6. PubMed ID: 15099875
[TBL] [Abstract][Full Text] [Related]
25. Significance of serum tumor markers carcinoembryonic antigen, CA 19-9, CA 125, and CA 15-3 in pre-orthotopic liver transplantation evaluation.
Pissaia A; Bernard D; Scatton O; Soubrane O; Conti F; Calmus Y
Transplant Proc; 2009 Mar; 41(2):682-4. PubMed ID: 19328956
[TBL] [Abstract][Full Text] [Related]
26. Letter commenting on the article "CA 125 expression pattern, prognosis and correlation with serum CA 125 in ovarian tumor patients" (104:508-515) by Hogdall, et al and on the Editorial "CA 125: megadaltons of novel opportunities" (104:505-507).
van Altena AM; de Hullu JA; Massuger LF
Gynecol Oncol; 2007 Nov; 107(2):355-6. PubMed ID: 17707896
[No Abstract] [Full Text] [Related]
27. CA-125 monitoring in ovarian cancer: patient survey responses to the results of the MRC/EORTC CA-125 Surveillance Trial.
Markman M; Petersen J; Belland A; Burg K
Oncology; 2010; 78(1):1-2. PubMed ID: 20215782
[No Abstract] [Full Text] [Related]
28. Prognostic role of CA-125 nadir in stage IV epithelial ovarian cancer.
Prat A; Parera M; Del Campo JM
J Clin Oncol; 2008 Apr; 26(10):1771-2; author reply 1772. PubMed ID: 18375912
[No Abstract] [Full Text] [Related]
29. [Screening for ovarian cancers: what is the role for marker levels?].
Dargent D
Gynecol Obstet Fertil; 2000 Nov; 28(11):855-9. PubMed ID: 11127045
[No Abstract] [Full Text] [Related]
30. CA125 for following up carcinoma of the bladder.
Wiwanitkit V
Urol Oncol; 2010; 28(2):226. PubMed ID: 20056459
[No Abstract] [Full Text] [Related]
31. Serum tumor markers in patients on dialysis and kidney transplantation.
Lye WC; Tambyah P; Leong SO; Lee EJ
Adv Perit Dial; 1994; 10():109-11. PubMed ID: 7528056
[TBL] [Abstract][Full Text] [Related]
32. CA-125 level preoperative assessment in early and advanced ovarian carcinoma.
Raspollini MR
Gynecol Oncol; 2007 Nov; 107(2):356-7; author reply 357-8. PubMed ID: 17716712
[No Abstract] [Full Text] [Related]
33. Elevated Serum CA-125 concentration in a patient with tuberculous peritonitis mimicking ovarian cancer.
Kucok M
J Reprod Med; 1998 Jul; 43(7):635-6. PubMed ID: 9693414
[No Abstract] [Full Text] [Related]
34. A case of intra-abdominal desmoplastic small-round-cell tumor with elevated serum CA125.
Yoshizawa J; Maie M; Eto T; Higashimoto Y; Saito T; Horie H; Urano F
Pediatr Surg Int; 2002 May; 18(4):238-40. PubMed ID: 12021969
[TBL] [Abstract][Full Text] [Related]
35. Lack of correlation between tumor markers (CA 125 and SCC) and systemic lupus erythematosus activity.
Miret C; Font J; Molina R; Filella X; Vivancos J; Muñoz-Rodriguez FJ; Cervera R; Ballesta AM; Ingelmo M
Anticancer Res; 1998; 18(2B):1341-4. PubMed ID: 9615813
[TBL] [Abstract][Full Text] [Related]
36. Normalization of the tumor marker CA-125 after oophorectomy in a patient with paraneoplastic cerebellar degeneration without detectable cancer.
Mason WP; Dalmau J; Curtin JP; Posner JB
Gynecol Oncol; 1997 Apr; 65(1):173-6. PubMed ID: 9103409
[TBL] [Abstract][Full Text] [Related]
37. Multiple myeloma with serous membrane involvement and increased CA-125 and CA 15-3.
Gunaldi M; Helvaci A; Demirel Yildirim N; Aydin D; Kara N
J BUON; 2011; 16(4):778. PubMed ID: 22331737
[No Abstract] [Full Text] [Related]
38. Prognostic value of CA125 in advanced heart failure patients.
Monteiro S; Franco F; Costa S; Monteiro P; Vieira H; Coelho L; Oliveira L; Providência LA
Int J Cardiol; 2010 Apr; 140(1):115-8. PubMed ID: 19285353
[TBL] [Abstract][Full Text] [Related]
39. [15 years CA-125 antigen: usefulness and limits. Apropos of 3 clinical cases].
Petignat P; Vajda D; Obrist R
Praxis (Bern 1994); 1998 Nov; 87(47):1602-5. PubMed ID: 9865132
[TBL] [Abstract][Full Text] [Related]
40. CA 125: marker of serosal inflammation in hereditary angioedema?
Cimbollek SH; Gonzalez-Quevedo T; Diaz Fernandez M
Allergy; 2005 Jun; 60(6):835-6. PubMed ID: 15876316
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
